HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
J Markowska Selected Research
J Markowska Research Topics
Disease
17
Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2000
8
Neoplasms (Cancer)
01/2022 - 01/2001
8
Carcinoma (Carcinomatosis)
11/2004 - 01/2000
3
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2011 - 01/2006
2
Ovarian Epithelial Carcinoma
01/2022 - 07/2007
2
Ascites
01/2013 - 01/2000
1
Leiomyoma (Uterine Fibroids)
01/2015
1
Wounds and Injuries (Trauma)
01/2011
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2011
1
Neoplasm Metastasis (Metastasis)
01/2009
1
Hypoxia (Hypoxemia)
01/2007
1
Endometriosis
01/2004
1
Disease Progression
01/2003
1
Persistent Infection
01/2001
1
Diabetic Retinopathy (Retinopathy, Diabetic)
01/2000
1
Macular Degeneration (Age-Related Maculopathy)
01/2000
1
Macular Edema
01/2000
Drug/Important Bio-Agent (IBA)
4
Proteins (Proteins, Gene)
FDA Link
01/2015 - 01/2001
3
Cytokines
IBA
01/2015 - 01/2004
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2013 - 01/2007
3
Platinum
IBA
11/2004 - 03/2003
2
Monoclonal Antibodies
IBA
01/2022 - 01/2003
2
Interleukin-6 (Interleukin 6)
IBA
07/2007 - 01/2004
2
Interleukin-8 (Interleukin 8)
IBA
07/2007 - 01/2004
2
CA-125 Antigen (CA 125 Antigen)
IBA
01/2003 - 01/2000
1
Carbohydrates
IBA
01/2022
1
Epitopes
IBA
01/2022
1
Mucin-1 (CA 15-3 Antigen)
IBA
01/2022
1
Gonadal Steroid Hormones (Sex Hormones)
IBA
01/2015
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2013
1
Bevacizumab (Avastin)
FDA Link
01/2013
1
Hyaluronic Acid (Hyaluronan)
IBA
01/2011
1
tissue polypeptide specific antigen
IBA
01/2009
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
01/2009
1
Tumor Biomarkers (Tumor Markers)
IBA
07/2007
1
Macrophage Colony-Stimulating Factor
IBA
07/2007
1
Facilitative Glucose Transport Proteins (Glucose Transporter)
IBA
01/2007
1
Antibodies
IBA
01/2007
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
01/2006
1
Trastuzumab (Herceptin)
FDA Link
11/2004
1
Angiogenesis Inhibitors
IBA
01/2004
1
Type II Tumor Necrosis Factor Receptors
IBA
01/2004
1
Cell Cycle Proteins
IBA
07/2003
1
Biological Products
IBA
07/2003
1
Cisplatin (Platino)
FDA Link
Generic
03/2003
1
Carboplatin (JM8)
FDA Link
Generic
01/2003
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2003
1
Transforming Growth Factor alpha (TGF-alpha)
IBA
01/2002
1
Oncogene Proteins (Oncogene Protein)
IBA
03/2001
1
Acute-Phase Proteins (Acute-Phase Protein)
IBA
01/2001
1
DNA (Deoxyribonucleic Acid)
IBA
01/2001
1
Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)
IBA
01/2001
1
Transferrin (beta 2 Transferrin)
IBA
01/2001
Therapy/Procedure
11
Drug Therapy (Chemotherapy)
01/2022 - 01/2000
4
Therapeutics
01/2022 - 01/2004
3
Aftercare (After-Treatment)
07/2007 - 01/2000
2
Radiotherapy
01/2011 - 01/2007
1
Operative Time
01/2015
1
Ovariectomy (Oophorectomy)
10/2013
1
Combined Modality Therapy
01/2009
1
Laparotomy
01/2000
1
Light Coagulation
01/2000
1
Hysterectomy
01/2000